Pancreatic Cancer Research

ResearcherUniversity of Maryland, BaltimoreNo recent work listed

Lehe Yang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-4592-8841; OpenAlex author ID A5101563853, A5101563854. Sources: OpenAlex.

Their work

Papers
4 (first author 3, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
7
Papers, trials and grants by year

2018: 1 paper · 2019: 2 papers · 2020: 1 paper

Papers 4

  1. Feedback activation of EGFR is the main cause for STAT3 inhibition-irresponsiveness in pancreatic cancer cells. First author DOI 10.1038/s41388-020-1271-y↗
  2. Alantolactone sensitizes human pancreatic cancer cells to EGFR inhibitors through the inhibition of STAT3 signaling. First author DOI 10.1002/mc.22951↗
  3. Rhein sensitizes human pancreatic cancer cells to EGFR inhibitors by inhibiting STAT3 pathway. Co-author DOI 10.1186/s13046-018-1015-9↗
  4. L61H46 shows potent efficacy against human pancreatic cancer through inhibiting STAT3 pathway. First author DOI 10.2147/cmar.s159090↗

Closest collaborators

The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Guang Liang · 4 shared papers, 2018–2020 · strength 0.36
  2. Chengguang Zhao · 4 shared papers, 2018–2020 · strength 0.36
  3. Xiaojing Du · 1 shared paper, 2020 · strength 0.10
  4. Ri Cui · 1 shared paper, 2020 · strength 0.10
  5. Hailun Zheng · 1 shared paper, 2019 · strength 0.09
  6. Encheng Bai · 1 shared paper, 2018 · strength 0.08
  7. Jiayuh Lin · 1 shared paper, 2018 · strength 0.08

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.